Lv1
68 积分 2020-08-26 加入
In vivo CAR T cell generation to treat cancer and autoimmune disease
10天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
21天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
23天前
已完结
Lupus nephritis
30天前
已完结
CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target
1个月前
已完结
Targeting the tumour cell surface in advanced prostate cancer
2个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
3个月前
已完结
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
4个月前
已完结
The Plasma Cell Signature in Autoimmune Disease
4个月前
已完结
Neoself-antigens are the primary target for autoreactive T cells in human lupus
5个月前
已完结
皖公网安备34019202002308
